Covid-19 | Press Releases

Greenville, N.C. – Nov. 02, 2021 Eligible community members who received their first two Pfizer-BioNTech (also known as Comirnaty) or Moderna COVID-19 vaccine doses at least 6 months ago, or the single dose of the Johnson & Johnson COVID-19 vaccine at least 2 months ago can now schedule a COVID-19 booster shot appointment through Vidant Health by visiting or calling 252-847-8000.

Vidant is offering booster shots to eligible community members in accordance with the North Carolina Department of Health and Human Services (NCDHHS) guidelines. Appointments can be scheduled at Vidant clinics throughout the region.

Community members who initially received a Pfizer or Moderna vaccine must wait at least 6 months since their second dose and meet at least one of the below criteria:

  • 65 or older
  • 18 or older and live in a long-term care facility
  • 18 or older, have a medical condition that puts you at high risk for severe COVID-19, and believe the benefit of receiving a booster outweighs the risk of receiving the booster.
  • 18 or older, have higher risk of exposure due to work or living situations, and believe the benefit of receiving a booster outweighs the risk of receiving the booster.

Community members who initially received a Johnson & Johnson vaccine must be 18 or older and wait at least 2 months from their initial dose.

Studies show that after being vaccinated against COVID-19, protection against the virus may decrease over time and provide less protection against the Delta variant. A booster shot may help increase immune response and improve protection against COVID-19, including the Delta variant.

There are now booster recommendations from the Centers for Disease Control and Prevention (CDC) and approval from the Food and Drug Administration (FDA) for all three available COVID-19 vaccines. Individuals can receive any brand of the COVID-19 vaccine for their booster shot, regardless of which brand they received initially.

In addition to the new booster shot eligibility, Vidant previously announced it is closely following CDC guidance to provide third doses to eligible immunocompromised community members. A third dose may prevent serious and possibly life-threatening complications of COVID-19 in immunocompromised people who may not have responded to their initial vaccine series.

Appointments can be scheduled at Vidant clinics and oncology practices throughout the region for community members who meet the below criteria:

  • You have had an organ or stem cell transplant.
  • You are receiving chemotherapy, other treatment for cancer or tumors, taking biologic agents (Humira, Enbrel, Remicade, etc.), taking high doses of prednisone, or taking similar drugs. Many of these drugs are used for treatment of cancer, Crohn’s disease, rheumatoid arthritis, or psoriasis.
  • You have a disease that weakens your immune system (like HIV or a primary immune system disease).
  • Your doctor told you that you are immunosuppressed.

The third dose is recommended for immunocompromised individuals at least 28 days after their second dose of the Pfizer or Moderna vaccine and is not recommended for those who received Johnson & Johnson’s Janssen COVID-19 vaccine. The Pfizer-BioNTech COVID-19 vaccine is also identified by its new brand name Comirnaty.

Please continue checking back to for the latest information on Vidant’s vaccine efforts.